TAK-063
TAK-063 Basic information
- Product Name:
- TAK-063
- Synonyms:
-
- TAK-063
- 1-[2-Fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one
- Balipodect
- TAK 063;TAK063
- Pyridone 6[1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one]
- CS-1534
- TAK-063(Balipodect)
- TAK063, TAK 063, TAK-063, BALIPODECT
- CAS:
- 1238697-26-1
- MF:
- C23H17FN6O2
- MW:
- 428.42
- Product Categories:
-
- Inhibitors
- Mol File:
- 1238697-26-1.mol
More
Less
TAK-063 Chemical Properties
- Boiling point:
- 612.3±65.0 °C(Predicted)
- Density
- 1.37±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMSO:55.0(Max Conc. mg/mL);128.38(Max Conc. mM)
- form
- A crystalline solid
- pka
- -0.34±0.12(Predicted)
- color
- Light yellow to yellow
More
Less
TAK-063 Usage And Synthesis
Description
TAK-063 is a potent inhibitor of phosphodiesterase 10A (PDE10A; IC50 = 0.3 nM). It is >15,000-fold selective for PDE10A over other PDEs and exhibits <50% inhibition at 91 receptors, ion channels, and enzymes at a concentration of 10 μM. TAK-063 (0.3 mg/kg) increases cAMP and cGMP levels by 1.3- and 2.14-fold, respectively, in the striatum of mice. It reverses hyperlocomotion induced by PCP (Item Nos. 14276 | ISO60194) with a minimum effective dose (MED) of 0.3 mg/kg, p.o., in wild-type mice but has no effect in PDE10A knockout mice at doses up to 1 mg/kg. TAK-063 also reverses hyperlocomotion induced by (+)-MK-801 (MED = 0.1 mg/kg, p.o.) but has no effect on plasma prolactin or glucose levels in rats.
TAK-063Supplier
Shanghai Boyle Chemical Co., Ltd.
- Tel
- sales@boylechem.com
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
- Tel
- 17702719238 17702719238
- sales@sun-shinechem.com
Dalian Meilun Biotech Co., Ltd.
- Tel
- 0411-62910999 13889544652
- sales@meilune.com
Haoyuan Chemexpress Co., Ltd.
- Tel
- 021-58950125
- info@chemexpress.com
EnliPharma Technology Co., Ltd
- Tel
- 0551-66399836 18955197623
- sales@enlipharma.com